Association between leptin and transaminases: 1-year follow-up study in 180 overweight children

Metabolism: Clinical and Experimental

Volumn 58, Issue 4, 2009, Pages 497-503

  Reinehr, Thomas ^a   Schmidt, Caroline ^a   de Sousa, Gideon ^a   Andler, Werner ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; INSULIN; LEPTIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEHAVIOR THERAPY; BODY MASS; BODY WEIGHT; CHILD; CLINICAL TRIAL; ECHOGRAPHY; EXERCISE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NUTRITION EDUCATION; OBESITY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; WEIGHT REDUCTION;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPTIN; LONGITUDINAL STUDIES; MALE; OVERWEIGHT;

EID: 62349091068     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.11.007     Document Type: Article

References (54)

1. Ebbeling C.A., Pawlak D.B., and Ludwig D.S. Childhood obesity: public-health crisis, common sense cure. Lancet 360 (2002) 473-482
2. Marion A.W., Baker A.J., and Dhawan A. Fatty liver disease in children. Arch Dis Child 89 (2004) 648-652
3. Patton H.M., Sirlin C., Behling C., Middleton M., Schwimmer J.B., and Lavine J.E. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 43 (2006) 413-427
4. Mathur P., Arora N.K., and Das M.K. Non-alcoholic fatty liver disease and childhood obesity. Indian J Pediatr 74 (2007) 401-407
5. Moran J.R., Ghishan F.K., Halter S.A., et al. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 78 (1983) 374-377
6. Baldrigde A.D., Perez-Atayde A.R., Graeme-Cook F., et al. Idiopathic steatohepatitis in childhood: a multi-centre retrospective study. J Pediatr 127 (1995) 700-704
7. Rashid M., and Roberts E.A. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 30 (2000) 48-53
8. Kinugasa A., Tsunamoto K., Furukawa N., et al. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 3 (1984) 408-414
9. Schwimmer J.B., Deutsch R., Kahen T., Lavine J.E., Stanley C., and Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 118 (2006) 1388-1393
10. Tominaga K., Kurat J.H., Chen Y.K., et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 40 (1995) 2002-2009
11. Molleston J.P., White F., Teckmann J., et al. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 97 (2002) 2460-2462
12. Shimada M., Hashimoto E., Taniai M., et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 37 (2002) 154-160
13. Tazawa Y., Noguchi H., Nishinomiya F., and Takada G. Effect of weight changes on serum transaminase activities in obese children. Acta Paediatr Jpn 39 (1997) 210-214
14. Bergomi A., Lughetti L., Corciulo N., et al. Italian multicentre study on liver damage in pediatric obesity. Int J Obes Relat Metabc Disord 22 Suppl 4 (1998) S22
15. Sagi R., Reif S., Neuman G., Webb M., Phillip M., and Shalitin S. Nonalcoholic fatty liver disease in overweight children and adolescents. Acta Paediatr 96 (2007) 1209-1213
16. Quirós-Tejeira R.E., Rivera C.A., Ziba T.T., Mehta N., Smith C.W., and Butte N.F. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or = 95th percentile. J Pediatr Gastroenterol Nutr 44 (2007) 228-236
17. Burgert T.S., Taksali S.E., Dziura J., Goodman T.R., Yeckel C.W., Papademetris X., et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 91 (2006) 4287-4294
18. Imhof A., Kratzer W., Boehm B., Meitinger K., Trischler G., Steinbach G., et al. Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. Eur J Epidemiol 22 (2007) 889-897
19. Chan D.F., Li A.M., Chu W.C., Chan M.H., Wong E.M., Liu E.K., et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 28 (2004) 1257-1263
20. Ratziu V., Giral P., Charlotte F., et al. Liver fibrosis in overweight patients. Gastroenterology 118 (2000) 1117-1123
21. Day C.P. Pathogenesis of steatohepatitis. Best practice and research. Clin Gastroenterol 16 (2002) 663-678
22. Parekh S., and Anania F.A. Abnormal lipid and glucose metabolism in obesity: implications for non-alcoholic fatty liver disease. Gastroenterol 132 (2007) 2191-2207
23. Saxena N.K., Ikeda K., Rockey D.C., et al. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 35 (2002) 762-771
24. Vigano M., Vergani A., Trombini P., Paleari F., and Piperno A. Insulin resistance influences iron metabolism and hepatic steatosis in type II diabetes. Gastroenterology 118 (2000) 986-987
25. Nobili V., Marcellini M., Devito R., Ciampalini P., Piemonte F., Comparcola D., et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 44 (2006) 458-465
26. Sartorio A., Del Col A., Agosti F., Mazzilli G., Bellentani S., Tiribelli C., et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 61 (2007) 877-883
27. Bonadonna R.C., Groop L., Kraemer N., et al. Obesity and insulin resistance in humans: a dose-response study. Metabolism 39 (1999) 452-459
28. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
29. Cole T.J., Bellizzi M.C., Flegal K.M., and Dietz W.H. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320 (2000) 1-6
30. Kromeyer-Hauschild K., Wabitsch M., Geller F., et al. Perzentile für den body mass index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 149 (2001) 807-810
31. Cole T.J. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44 (1990) 45-60
32. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
33. Blum W.F., Englaro P., Hanitsch S., Juul A., Hertel N.T., Müller J., et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 82 (1997) 2904-2910
34. American Gastroenterological Association. American Gastroenterological Association medical position statement. Gastroenterology 123 (2002) 1702-1704
35. Saverymuttu S.H., Joseph A.E.A., and Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 292 (1996) 13-15
36. Reinehr T., de Sousa G., Toschke M., and Andler W. Long-term follow-up of cardiovascular risk factors in obese children after intervention. Am J Clin Nutr 84 (2006) 490-496
37. Reinehr T., Temmesfeld M., Kersting M., de Sousa G., and Toschke A.M. Four year follow-up of children and adolescents participating in an obesity intervention program. Int J Obes 31 (2007) 1074-1077
38. Reinehr T., and Andler W. Changes in the atherogenic risk-factor profile according to degree of reduction of overweight. Arch Dis Child 89 (2004) 419-422
39. Wanless I.R., and Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity; an autopsy study with analysis of risk factors. Hepatology 12 (1990) 1106-1110
40. Reddy J.K. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal β-oxidation, PPARα, and steatohepatitis. Am J Physiol Gastrointest Liver Physiol 281 (2001) G1333-g1339
41. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J Clin Invest 106 (2000) 473-481
42. Lago R., Gómez R., Lago F., Gómez-Reino J., and Gualillo O. Leptin beyond body weight regulation-current concepts concerning its role in immune function and inflammation. Cell Immunol. 252 (2008) 139-145
43. Uribe M., Zamora-Valdés D., Moreno-Portillo M., Bermejo-Martínez L., Pichardo-Bahena R., Baptista-González H.A., et al. Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease. Ann Hepatol. 7 (2008) 67-71
44. Wieckowska A., Papouchado B.G., Li Z., Lopez R., Zein N.N., and Feldstein A.E. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 103 (2008) 1372-1379
45. Carter-Kent C., Zein N.N., and Feldstein A.E. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol. 103 (2008) 1036-1042
46. Yoneda M., Hotta K., Nozaki Y., Endo H., Uchiyama T., Mawatari H., et al. Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol. 8 (2008) 27
47. Ciba I., and Widhalm K. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. Acta Paediatr 96 (2007) 109-112
48. Wallace T.M., and Matthews D.R. The assessment of insulin resistance in man. Diabet Med 19 (2002) 527-534
49. Uwaifo G.I., Fallon E.M., Chin J., et al. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 25 (2002) 2081-2087
50. Sanyal A.J., Campbell-Sargent C., Mirshahi F., et al. Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120 (2001) 1183-1192
51. Marchesini G., Brizi M., Bianchi G., et al. Non-alcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
52. Struben V.M.D., Hespenheide E.E., and Caldwell S. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 108 (2000) 9-13
53. Palmer M., and Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 99 (1990) 1408-1413
54. Vajro P., Fontanella A., Perna C., Orso G., Tedesco M., and De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 125 (1994) 239-241